Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

MYSE vs ANGI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
MYSE
Myseum Inc.

Software - Application

TechnologyNASDAQ • US
Market Cap$6M
5Y Perf.-97.3%
ANGI
Angi Inc.

Internet Content & Information

Communication ServicesNASDAQ • US
Market Cap$192M
5Y Perf.-95.5%

MYSE vs ANGI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
MYSE logoMYSE
ANGI logoANGI
IndustrySoftware - ApplicationInternet Content & Information
Market Cap$6M$192M
Revenue (TTM)$581.00$1.02B
Net Income (TTM)$-5M$20M
Gross Margin-3631.6%91.1%
Operating Margin-9397.7%4.8%
Forward P/E5.6x
Total Debt$0.00$498M
Cash & Equiv.$1M$304M

MYSE vs ANGILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

MYSE
ANGI
StockAug 21May 26Return
Myseum Inc. (MYSE)1002.7-97.3%
Angi Inc. (ANGI)1004.5-95.5%

Price return only. Dividends and distributions are not included.

Quick Verdict: MYSE vs ANGI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: ANGI leads in 4 of 6 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Myseum Inc. is the stronger pick specifically for recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
MYSE
Myseum Inc.
The Long-Run Compounder

MYSE is the clearest fit if your priority is long-term compounding.

  • -94.1% 10Y total return vs ANGI's -94.5%
  • -17.9% vs ANGI's -57.4%
Best for: long-term compounding
ANGI
Angi Inc.
The Income Pick

ANGI carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 1.85
  • Rev growth -13.0%, EPS growth 32.4%, 3Y rev CAGR -16.4%
  • Lower volatility, beta 1.85, Low D/E 53.7%, current ratio 1.65x
Best for: income & stability and growth exposure
See the full category breakdown
CategoryWinnerWhy
GrowthANGI logoANGI-13.0% revenue growth vs MYSE's -35.1%
Quality / MarginsANGI logoANGI1.9% margin vs MYSE's -8.2K%
Stability / SafetyANGI logoANGIBeta 1.85 vs MYSE's 2.34
DividendsTieNeither stock pays a meaningful dividend
Momentum (1Y)MYSE logoMYSE-17.9% vs ANGI's -57.4%
Efficiency (ROA)ANGI logoANGI1.2% ROA vs MYSE's -70.0%, ROIC 5.0% vs -90.3%

MYSE vs ANGI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

MYSEMyseum Inc.

Segment breakdown not available.

ANGIAngi Inc.
FY 2025
U.S. Segment
90.5%$43M
International Segment
9.5%$4M

MYSE vs ANGI — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLANGILAGGINGMYSE

Income & Cash Flow (Last 12 Months)

ANGI leads this category, winning 4 of 6 comparable metrics.

ANGI is the larger business by revenue, generating $1.0B annually — 1760364.9x MYSE's $581. ANGI is the more profitable business, keeping 1.9% of every revenue dollar as net income compared to MYSE's -8154.6%. On growth, MYSE holds the edge at +4.3% YoY revenue growth, suggesting stronger near-term business momentum.

MetricMYSE logoMYSEMyseum Inc.ANGI logoANGIAngi Inc.
RevenueTrailing 12 months$581$1.0B
EBITDAEarnings before interest/tax-$5M$86M
Net IncomeAfter-tax profit-$5M$20M
Free Cash FlowCash after capex-$4M$26M
Gross MarginGross profit ÷ Revenue-3631.6%+91.1%
Operating MarginEBIT ÷ Revenue-9397.7%+4.8%
Net MarginNet income ÷ Revenue-8154.6%+1.9%
FCF MarginFCF ÷ Revenue-7575.0%+2.5%
Rev. Growth (YoY)Latest quarter vs prior year+4.3%-3.2%
EPS Growth (YoY)Latest quarter vs prior year+33.3%-163.3%
ANGI leads this category, winning 4 of 6 comparable metrics.

Valuation Metrics

ANGI leads this category, winning 2 of 3 comparable metrics.
MetricMYSE logoMYSEMyseum Inc.ANGI logoANGIAngi Inc.
Market CapShares × price$6M$192M
Enterprise ValueMkt cap + debt − cash$5M$386M
Trailing P/EPrice ÷ TTM EPS-1.41x5.10x
Forward P/EPrice ÷ next-FY EPS est.5.57x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple3.08x
Price / SalesMarket cap ÷ Revenue9999.00x0.19x
Price / BookPrice ÷ Book value/share1.26x0.24x
Price / FCFMarket cap ÷ FCF4.22x
ANGI leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

ANGI leads this category, winning 6 of 8 comparable metrics.

ANGI delivers a 2.1% return on equity — every $100 of shareholder capital generates $2 in annual profit, vs $-83 for MYSE. On the Piotroski fundamental quality scale (0–9), ANGI scores 6/9 vs MYSE's 2/9, reflecting solid financial health.

MetricMYSE logoMYSEMyseum Inc.ANGI logoANGIAngi Inc.
ROE (TTM)Return on equity-83.2%+2.1%
ROA (TTM)Return on assets-70.0%+1.2%
ROICReturn on invested capital-90.3%+5.0%
ROCEReturn on capital employed-97.4%+5.1%
Piotroski ScoreFundamental quality 0–926
Debt / EquityFinancial leverage0.54x
Net DebtTotal debt minus cash-$1M$194M
Cash & Equiv.Liquid assets$1M$304M
Total DebtShort + long-term debt$0$498M
Interest CoverageEBIT ÷ Interest expense-55.49x5.38x
ANGI leads this category, winning 6 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

MYSE leads this category, winning 6 of 6 comparable metrics.

A $10,000 investment in MYSE five years ago would be worth $591 today (with dividends reinvested), compared to $341 for ANGI. Over the past 12 months, MYSE leads with a -17.9% total return vs ANGI's -57.4%. The 3-year compound annual growth rate (CAGR) favors MYSE at -16.1% vs ANGI's -42.8% — a key indicator of consistent wealth creation.

MetricMYSE logoMYSEMyseum Inc.ANGI logoANGIAngi Inc.
YTD ReturnYear-to-date+12.8%-62.1%
1-Year ReturnPast 12 months-17.9%-57.4%
3-Year ReturnCumulative with dividends-40.9%-81.3%
5-Year ReturnCumulative with dividends-94.1%-96.6%
10-Year ReturnCumulative with dividends-94.1%-94.5%
CAGR (3Y)Annualised 3-year return-16.1%-42.8%
MYSE leads this category, winning 6 of 6 comparable metrics.

Risk & Volatility

Evenly matched — MYSE and ANGI each lead in 1 of 2 comparable metrics.

ANGI is the less volatile stock with a 1.85 beta — it tends to amplify market swings less than MYSE's 2.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MYSE currently trades 35.0% from its 52-week high vs ANGI's 24.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricMYSE logoMYSEMyseum Inc.ANGI logoANGIAngi Inc.
Beta (5Y)Sensitivity to S&P 5002.34x1.85x
52-Week HighHighest price in past year$5.77$19.42
52-Week LowLowest price in past year$1.31$4.53
% of 52W HighCurrent price vs 52-week peak+35.0%+24.7%
RSI (14)Momentum oscillator 0–10045.349.6
Avg Volume (50D)Average daily shares traded5.0M1.1M
Evenly matched — MYSE and ANGI each lead in 1 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.
MetricMYSE logoMYSEMyseum Inc.ANGI logoANGIAngi Inc.
Analyst RatingConsensus buy/hold/sellHold
Price TargetConsensus 12-month target$12.75
# AnalystsCovering analysts54
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises1
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%+77.4%
Insufficient data to determine a leader in this category.
Key Takeaway

ANGI leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). MYSE leads in 1 (Total Returns). 1 tied.

Best OverallAngi Inc. (ANGI)Leads 3 of 6 categories
Loading custom metrics...

MYSE vs ANGI: Frequently Asked Questions

8 questions · data-driven answers · updated daily

01

Is MYSE or ANGI a better buy right now?

For growth investors, Angi Inc.

(ANGI) is the stronger pick with -13. 0% revenue growth year-over-year, versus -35. 1% for Myseum Inc. (MYSE). Angi Inc. (ANGI) offers the better valuation at 5. 1x trailing P/E (5. 6x forward), making it the more compelling value choice. Analysts rate Angi Inc. (ANGI) a "Hold" — based on 54 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — MYSE or ANGI?

Over the past 5 years, Myseum Inc.

(MYSE) delivered a total return of -94. 1%, compared to -96. 6% for Angi Inc. (ANGI). Over 10 years, the gap is even starker: MYSE returned -94. 1% versus ANGI's -94. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — MYSE or ANGI?

By beta (market sensitivity over 5 years), Angi Inc.

(ANGI) is the lower-risk stock at 1. 85β versus Myseum Inc. 's 2. 34β — meaning MYSE is approximately 27% more volatile than ANGI relative to the S&P 500.

04

Which is growing faster — MYSE or ANGI?

By revenue growth (latest reported year), Angi Inc.

(ANGI) is pulling ahead at -13. 0% versus -35. 1% for Myseum Inc. (MYSE). On earnings-per-share growth, the picture is similar: Myseum Inc. grew EPS 65. 5% year-over-year, compared to 32. 4% for Angi Inc.. Over a 3-year CAGR, ANGI leads at -16. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — MYSE or ANGI?

Angi Inc.

(ANGI) is the more profitable company, earning 4. 3% net margin versus -9722. 8% for Myseum Inc. — meaning it keeps 4. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ANGI leads at 7. 6% versus -12112. 2% for MYSE. At the gross margin level — before operating expenses — ANGI leads at 90. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Which pays a better dividend — MYSE or ANGI?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

07

Is MYSE or ANGI better for a retirement portfolio?

For long-horizon retirement investors, Angi Inc.

(ANGI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding. Myseum Inc. (MYSE) carries a higher beta of 2. 34 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ANGI: -94. 5%, MYSE: -94. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

08

What are the main differences between MYSE and ANGI?

These companies operate in different sectors (MYSE (Technology) and ANGI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MYSE is a small-cap quality compounder stock; ANGI is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

MYSE

High-Growth Disruptor

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 214%
Run This Screen
Stocks Like

ANGI

Quality Business

  • Sector: Communication Services
  • Market Cap > $100B
  • Gross Margin > 54%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform MYSE and ANGI on the metrics below

Revenue Growth>
%
(MYSE: 429.0% · ANGI: -3.2%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.